In this study of 13208 patients with #COPD the QRISK3 score underestimated their 10 year risk of #cardiovascular events. On average, the observed risk was 52% higher than QRISK3 predicted (33.5% vs 22.1%), & more so in patients aged <65 years @ThoraxBMJ
https://t.co/OMOsSFld2D
FULLY FUNDED PhD STUDENTSHIP @TeesUniSHLS investigating the potential of perturbation balance training for people with COPD. Join a team with clinical, digital and lab-based skills. @utility_back https://t.co/wFqaoWTXsC
A new one-stop clinic has launched in Northumberland to support drug and alcohol users with their respiratory health.
This project also focuses on tackling health inequalities across the region, as Prof Stephen Bourke explains.
To learn more, visit: https://t.co/zcfdcoApyx.
🚨 RECRUITMENT COMPLETE🚨
Thanks to all the fantastic @TrialCLEAR teams we today achieved recruitment target 🔥
Special mention for @michellespence_ who randomised the FIRST & LAST ever CLEAR patients! A huge amount of work from so many people in between! Thank you everyone 🙌
Prednisolone given universally for COPD exacerbations causes harm without any benefit. Patients deserve blood eosinophil-guided prednisolone treatment for COPD exacerbations. https://t.co/7Q5W4r2uFo
Our Respiratory Speech & Language Therapy WEBSITE IS LIVE!!🤩
https://t.co/N4OkYFp8CW
We hope it’s valuable for patients & health professionals far & wide.
It covers:
✅Diagnosis eduction
✅Breathing exercises
✅Throat care
✅Specialist clinics
And more…
Please share 🙏
WHAT’S YOUR BIG IDEA💡
🚨 We are open to expressions of interest for our next round of studies! 🚨
No research experience required!
We offer support to develop your idea
Follow the link below with a one sentence summary of your idea to get started
https://t.co/590YZ2SbxE
** Attending #BTSWinter2022? **
Come say hello 👋🏽 at our stand on level 3 in the coffee break.
Find out more about the new INSPIRE research network and how you can get involved!
(And nab yourself a 🖊 😉)
🥁Drumroll please…🥁 Calling all Resp trainees! ERUPT database is LIVE! Have you signed your hospital up? It’s not too late to take part in INSPIREs first national collaborative study, designed and led by trainees for trainees.
@LewisStanding1@joekibbler@NorthumbriaLung Yes, guidance encourages teams to think about CVD and test if possible. Also advises bnp in those with no obv indication for echo. Guidance not always followed but that's why decent number of new diagnoses made in UC.
Great work @joekibbler. Presenting early results from SCATECOPD #ERSCongress. In people hospitalised with COPD exac, 50% with LVSD not on BB/ACE and new cardiac diagnoses found in 75% if you look. Opportunity to improve care for our patients with #copd. @NorthumbriaLung.
Readmissions following a first #COPD exacerbation-related hospitalization are common, non-respiratory events constitute the majority. So, also treatment targeting non-respiratory causes of hospitalization should be considered to decrease readmissions.
https://t.co/Duw4KbrrTX
@Anna_L_Mitchell @geordielungdoc@OlenkaDuffy@nickydlane@KarenMarshall02 I thought it was related, in part, to excess glucocorticoids. But I don't know much about them 'ormones. Maybe for another session. Hope tomorrow goes well